Home LiteratureArticle Details
PMID: 3422628 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Transforming growth factor beta regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts.

FEBS letters ·Vol. 228 ·No. 1 ·1988-02-08 ·Pages 42-4

Balza E, Borsi L, Allemanni G, Zardi L

Abstract

Fibronectin (FN) polymorphism is caused by alternative splicing patterns in at least three regions of the primary transcript of a single gene. Using a monoclonal antibody (Mab) specific for an FN segment (ED-A), that can be included or omitted from the molecule depending on the pattern of splicing, we have examined whether transforming growth factor beta (TGF-beta) and dexamethasone, which are both known to increase the level of total FN, regulate the levels of different FN isoforms. We found that, while dexamethasone does not significantly change the ratio between the total FN and the ED-A containing FN, TGF-beta preferentially increases the expression of the FN isoform containing the ED-A sequence.

MeSH Terms
Adult Cells, Cultured Dexamethasone/pharmacology Fibroblasts/metabolism Fibronectins/metabolism Gene Expression Regulation Humans Peptides/pharmacology Sequence Homology, Nucleic Acid Transcription, Genetic Transforming Growth Factors
Chemicals
Fibronectins Peptides Transforming Growth Factors Dexamethasone
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Balza E
Cell Biology Laboratory, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
Borsi L
Allemanni G
Zardi L
Article Info
Journal
FEBS letters
Abbr.
FEBS Lett
ISSN
0014-5793
Published
1988-02-08
Pages
42-4
Language
English
Region
England
NLM ID
0155157
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]